الرئيسية » أرشيف الكاتب: tifwp

أرشيف الكاتب: tifwp

      IS BETA – THALASSAEMIA OR SICKLE CELL DISEASE IN YOUR PIPELINE?   LEARN ABOUT PATIENTS’ EXPECTATIONS, PERSPECTIVE, CHALLENGES AND BURDEN OF DISEASE BY ENGAGING WITH TIF’s INTERNATIONAL PATIENT ADVOCACY GROUP!   The Thalassaemia International Federation (TIF) is delighted to announce the establishment of TIF’s Patient Advocacy Group ...

أكمل القراءة »

Rapamycin

  Update: 25 November 2019 No update available.   Update: 27 September 2019 Rapamycin, a drug widely used for almost 20 years to protect organ transplant patients, has been found to reduce, in mice, the build up of toxic proteins that destroy red blood cells in β-thalassaemia. Investigators are moving ...

أكمل القراءة »

Mitapivat (AG-348)

  Update: 25 November 2019 No update available.   Update: 27 September 2019 DRIVE PK is an ongoing global, open-label, Phase 2, safety and efficacy study evaluating Mitapivat in adults with PK deficiency who do not receive regular transfusions. It is the first clinical trial in adults with PK deficiency. ...

أكمل القراءة »

International Thalassaemia Day 2019 – Get inspired, get involved!

This is how this year’s voting results were shaped: Universal access to quality thalassaemia healthcare services: Building bridges with and for patients (Winning theme, 196 votes) Patients’ voice at the frontline: Advocating for a better future in thalassaemia care and management (112 votes) The globalization of thalassaemia – Common challenges ...

أكمل القراءة »

Sickle Cell Disease

CRISPR gene editing (SCD)   Update: 25 November 2019 CRISPR Therapeutics and Vertex Pharmaceuticals announced positive, interim data from the first two patients with severe hemoglobinopathies treated with the investigational CRISPR/Cas9 gene-editing therapy CTX001. 1 patient with severe sickle cell disease (SCD) received CTX001 in mid-2019 and data for this ...

أكمل القراءة »

Apotransferrin

  Update: 25 November 2019 No update available.   Update: 27 September 2019 No update available   Update: 30 July 2019 No update available.   Update: 30 May 2019  Apotransferrinhas a physiological role in the transportation and distribution of iron among the body organs. Apotrasferrin has received orphan drug designation ...

أكمل القراءة »